Explain New ADHD Forms Don't Offer Much Advantage Over Older Meds

March 2016

Reps will promote new stimulant products for ADHD...touting their unique dosage forms or durations.

But don't get too excited...and put the hype into perspective.

Aptensio XR (ap-TEN-see-oh) and QuilliChew ER (kwil-ih-CHOO) are new forms of methylphenidate ER. Aptensio XR is the first 12-hour SPRINKLE cap...and QuilliChew ER will be the first 8-hour CHEWABLE tab.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Cardiology Use an ACEI or an ARB for Hypertension or Diabetic Kidney Disease
Depression Recommend Combining Antidepressants from Different Classes
Vitamins & Minerals Explain Why Fewer Patients Will Have Vitamin D Blood Levels Drawn
Fungal Infections Caution About Fluconazole for Vaginal Candidiasis During Pregnancy
Antithrombotics Don't Assume DOACs are Preferred for All Patients with Venous Thromboembolism
Antithrombotics Avoid Using the Abbreviation "tPA" for Alteplase
ADHD Explain New ADHD Forms Don't Offer Much Advantage Over Older Meds
Med Adherence Think of Smartphone Apps as Another Tool in Your Adherence Toolbox
Tapering Don't Stop Paroxetine "Cold Turkey"
Specialty Meds Document Specialty Meds in the EHR, Even if You're NOT the Prescriber
Statins Use These Tips to Handle Confusing Statin Interactions

Explain New ADHD Forms Don't Offer Much Advantage Over Older Meds

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents